IDIOPATHIC PULMONARY FIBROSIS
Clinical trials for IDIOPATHIC PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for IDIOPATHIC PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new Drug's safety alongside standard IPF therapies
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a potential new drug for Idiopathic Pulmonary Fibrosis (IPF), called ENV-101, interacts with two standard medications (nintedanib and pirfenidone). It will enroll 57 healthy participants to measure how the body absorbs and processes t…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE1 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
AI learns to forecast deadly lung Disease's path
Knowledge-focused Not yet recruitingThis study aims to develop a computer model that can predict how idiopathic pulmonary fibrosis (IPF) will progress in individual patients. Researchers will analyze past medical records from 1,000 patients across Italian hospitals to teach the model what patterns lead to faster de…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS
Sponsor: University of Modena and Reggio Emilia • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC